EIR Ventures

EIR Ventures is a life science venture capital firm supported by InnovFin Equity and Saminvest AB. They focus on financing the development of innovative medicine and have a portfolio of companies across various therapeutic areas.

EIR Ventures favicon
Founded โ€” ยท Venture Capital
Stockholm (Sweden), Copenhagen (Denmark)
Investment Stages
Series A
Series B
Markets
Life Science
Portfolio Companies

Moleculent, RAPP, GutCRINE, Hoba Therapeutics, Scenic Biotech, SACRA Therapeutics, ArgusEye, Pretzel, IO Biotech, Galecto Biotech, Purpose Pharma, Henlez, Attgeno, Cinclus Pharma, Strike Pharma, Dania Tx, ISD-Immunotech, one-carbon Therapeutics, Synklino, Sortina Pharma

Share this page